DK155882A - Mikroemulsion til cutan brug - Google Patents

Mikroemulsion til cutan brug Download PDF

Info

Publication number
DK155882A
DK155882A DK155882A DK155882A DK155882A DK 155882 A DK155882 A DK 155882A DK 155882 A DK155882 A DK 155882A DK 155882 A DK155882 A DK 155882A DK 155882 A DK155882 A DK 155882A
Authority
DK
Denmark
Prior art keywords
cutan
microemulsion
cutan use
Prior art date
Application number
DK155882A
Other languages
Danish (da)
English (en)
Inventor
J Franz
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH2327/81A external-priority patent/CH653256A5/de
Priority claimed from CH2631/81A external-priority patent/CH647149A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK155882A publication Critical patent/DK155882A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK155882A 1981-04-06 1982-04-05 Mikroemulsion til cutan brug DK155882A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH2327/81A CH653256A5 (en) 1981-04-06 1981-04-06 Microemulsion for cutaneous use
CH2631/81A CH647149A5 (en) 1981-04-22 1981-04-22 Composition with 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole for cutaneous use
CH327881 1981-05-20

Publications (1)

Publication Number Publication Date
DK155882A true DK155882A (da) 1982-12-10

Family

ID=27173625

Family Applications (1)

Application Number Title Priority Date Filing Date
DK155882A DK155882A (da) 1981-04-06 1982-04-05 Mikroemulsion til cutan brug

Country Status (16)

Country Link
AU (1) AU564570B2 (fi)
CA (1) CA1192496A (fi)
DE (1) DE3212053A1 (fi)
DK (1) DK155882A (fi)
ES (1) ES511169A0 (fi)
FI (1) FI821123L (fi)
FR (1) FR2502951B1 (fi)
GB (2) GB2098865B (fi)
GR (1) GR75462B (fi)
IL (1) IL65424A0 (fi)
IT (1) IT8220611A0 (fi)
MY (1) MY8600571A (fi)
NL (1) NL8201413A (fi)
NZ (1) NZ200232A (fi)
PT (1) PT74703B (fi)
SE (1) SE8202172L (fi)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655656B (fi) * 1982-10-07 1986-05-15
CA1225594A (en) * 1983-05-20 1987-08-18 Jourge Heller Method for percutaneously administering physiologically active agents
DE3406497A1 (de) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
HU197847B (en) * 1984-03-01 1989-06-28 Sandoz Ag Process for producing therapeutical preparations suitable for transdermatic treating
US5364628A (en) * 1985-05-31 1994-11-15 Sandoz Ltd. Pharmaceutical compositions
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
JPS61280426A (ja) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
US4767625A (en) * 1985-09-02 1988-08-30 Kao Corporation Lamella type single phase liquid crystal composition and oil-base cosmetic compositions using the same
US4690774A (en) 1985-09-11 1987-09-01 Chesebrough Pond's Inc. Novel translucent water in oil emulsions
US4797272A (en) * 1985-11-15 1989-01-10 Eli Lilly And Company Water-in-oil microemulsions for cosmetic uses
DE3805744C2 (de) * 1987-03-04 1999-09-23 Novartis Ag Phenylcarbamate zur Hemmung der Acetylcholinesterase
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
DE3908047A1 (de) * 1989-03-13 1990-09-20 Desitin Arzneimittel Gmbh Hochdisperse pharmazeutische zusammensetzung
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
US5149719A (en) * 1990-04-27 1992-09-22 Minnesota Mining And Manufacturing Company Composition for transdermal penetration of medicaments
FR2673537B1 (fr) 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
JPH06507172A (ja) * 1991-04-19 1994-08-11 アフィニティー　バイオテック，インコーポレイテッド 転換可能なミクロエマルジョン処方剤
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
GB9111611D0 (en) * 1991-05-30 1991-07-24 Sandoz Ltd Liposomes
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
GB9126209D0 (en) * 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
AU3326493A (en) * 1991-12-16 1993-07-19 Alza Corporation Improved formulations with hydrophobic permeation enhancers
US5629019A (en) * 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
JP3631490B2 (ja) 1992-05-13 2005-03-23 ノバルティス ファーマ株式会社 シクロスポリン含有眼科用組成物
EP0589843B1 (en) 1992-09-25 2001-11-28 Novartis AG Pharmaceutical compositions containing cyclosporins
WO1994008610A1 (en) * 1992-10-16 1994-04-28 Smithkline Beecham Corporation Pharmaceutical emulsion compositions
WO1994019000A1 (en) * 1993-02-17 1994-09-01 Smithkline Beecham Corporation Microemulsions containing pharmaceutical compositions
RU2158601C2 (ru) 1994-11-03 2000-11-10 Новартис Аг Новые лекарственные формы циклоспорина для орального применения с простым составом и высокой биодоступностью и способ их получения
DE4442999A1 (de) * 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten
DE19549852B4 (de) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
RU2211047C2 (ru) 1997-01-30 2003-08-27 Новартис Аг Желатиновые капсулы с твердым покрытием, включающие фармацевтические композиции, практически не содержащие масел
IN188719B (fi) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
US6391282B1 (en) * 1997-11-10 2002-05-21 Flemington Pharmaceutical Corp. Antihistamine sprays and ointments for relief of delayed contact dermatitis
DE19825856A1 (de) * 1998-06-10 1999-12-16 Labtec Gmbh Topische Arzneimittelzubereitung
IL143580A0 (en) * 1998-12-11 2002-04-21 Pharmasolutions Inc Pharmaceutical compositions containing lipophilic drugs and methods for the preparation thereof
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
EP1644004A4 (en) * 2003-06-20 2010-10-06 Ronald Aung-Din LOCAL THERAPY FOR THE TREATMENT OF MIGRAINS, MUSCLE CLARIFICATIONS, MUSCLE SPASMS, SPASTICITY AND RELATED CONDITIONS
EP1706128B1 (en) 2003-12-08 2010-07-21 CPEX Pharmaceuticals, Inc. Pharmaceutical compositions and methods for insulin treatment
US7740875B2 (en) 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US9308203B2 (en) * 2008-10-01 2016-04-12 Taiwan Biotech Co., Ltd. Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
EP3435977A4 (en) 2016-04-01 2019-10-16 Therapeuticsmd, Inc. PHARMACEUTICAL COMPOSITION OF STEROID HORMONE
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH570401A5 (fi) * 1972-05-09 1975-12-15 Wander Ag Dr A
GB1559811A (en) * 1975-07-28 1980-01-30 Sandoz Ltd Pharmaceutically active benzothiadiazole derivatives
CH632268A5 (de) * 1977-01-14 1982-09-30 Sandoz Ag Verfahren zur herstellung von neuen heterocyclylaminoderivaten.

Also Published As

Publication number Publication date
NZ200232A (en) 1985-08-16
FR2502951B1 (fr) 1985-12-06
FR2502951A1 (fr) 1982-10-08
FI821123A0 (fi) 1982-03-31
GB2148711A (en) 1985-06-05
SE8202172L (sv) 1982-10-07
GB2148711B (en) 1985-12-18
ES8308698A1 (es) 1983-10-01
PT74703A (en) 1982-05-01
PT74703B (en) 1984-05-30
NL8201413A (nl) 1982-11-01
MY8600571A (en) 1986-12-31
IT8220611A0 (it) 1982-04-06
DE3212053A1 (de) 1982-10-21
FI821123L (fi) 1982-10-07
IL65424A0 (en) 1982-07-30
GB2098865B (en) 1985-12-18
AU8233482A (en) 1982-10-14
GB8408654D0 (en) 1984-05-16
CA1192496A (en) 1985-08-27
AU564570B2 (en) 1987-08-20
ES511169A0 (es) 1983-10-01
GB2098865A (en) 1982-12-01
GR75462B (fi) 1984-07-20

Similar Documents

Publication Publication Date Title
DK155882A (da) Mikroemulsion til cutan brug
NO157089C (no) Verkt for sponfraskillende bearbeiding.
IT8248344A0 (it) Sacchetto per drenaggio chirurgico
DK156479C (da) 2-(2-fluor-4-halogen-5-substitueret-phenyl)-hydantoinderivater
DK474882A (da) Vaevskulturmedium
FI813911L (fi) Kirurgiskt foerbindningsinstrument
DK158794C (da) Flydende hudrensemiddel
NL176234C (nl) Trilinrichting.
DK511282A (da) I-bjaelke
FR2500706B1 (fr) Transducteur electrostatique-acoustique
FI811763A0 (fi) Valv foer elektrisk smaeltugn
AT381435B (de) Pflug
FI821404L (fi) Med kaerna foersett hoelje med hoeg taethet
ES511405A0 (es) "procedimiento de preparar compuestos 1(2h)-isoquinolonicos y similares".
FI822499L (fi) Modellerings- eller formmassa
FI823419A0 (fi) Icke-magnetisk legering med hoeg haordhet
FI834289A (fi) Medbringare foer en draganordning.
FI823865L (fi) Co2-vapen
IT8224818A0 (it) Procedimento per la preparazione del7-metil-3-metilen-7-otten-1-il-propionato.
IT1137357B (it) Diamantatrice
FI820474L (fi) Baeranordning foer kirurgiskt soemmaterial
FI823496L (fi) Papperstorkning med hoeg hastighet
BR8207275A (pt) Guindaste
BR6101082U (pt) Embalagem descartavel
IT8133815V0 (it) Irene

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
PUP Patent expired